The Nevada National Board Professional Learning Institute | Juel | Activity http://www.nationalboardinstitute.com/members/malecourt9/activity/ Activity feed for Juel. Fri, 23 May 2025 17:06:54 -0700 https://buddypress.org/?v=9.1.1 en-US 30 hourly 2 66b99cca08d3939223151cb5eb871d8b Juel posted an update: 28 [0.30] mg/dL, P = .18) were comparable to the reference […] http://www.nationalboardinstitute.com/activity/p/41400/ Sat, 08 Feb 2025 08:45:19 -0800 28 [0.30] mg/dL, P = .18) were comparable to the reference method. NGAL was an independent predictor of AKI (odds ratio, 1.6; 95% CI, 0.08-5.20; P = .01). The optimal ML model achieved an accuracy, sensitivity, and specificity of 96%, 92.3%, and 97.7%, respectively, with NGAL, creatinine, and UOP as features. Area under the receiver operator curve…[Read more]

]]> 0 59142b29a1466da8aba492c44ae2bd22 Juel posted an update: similar between groups preoperatively; postoperatively, […] http://www.nationalboardinstitute.com/activity/p/36981/ Mon, 03 Feb 2025 08:33:34 -0800 similar between groups preoperatively; postoperatively, patients without complications had significantly higher Activities of Daily Living and Quality of Life scores (

< .05). Demographically, there was no difference in age, sex, body mass index, Charlson Comorbidity Index, depression/anxiety, or pain management between the 2 groups.…[Read more]

]]> 0 85ac02f7c38c80aba43ae2cac10df6d6 Juel posted an update: 0 and > 35.0kg/m or who had lower baseline HbA1c. Sem […] http://www.nationalboardinstitute.com/activity/p/28004/ Tue, 28 Jan 2025 10:25:49 -0800 0 and > 35.0kg/m

or who had lower baseline HbA1c. Semaglutide was generally well tolerated, although adverse-effects limited use in 18 patients (9.5%).

Semaglutide provided clinically and statistically significant reductions in HbA1c, body weight, lipids and liver enzymes.

Semaglutide provided clinically and statistically sig…[Read more]

]]> 0 f80e7ac241f6304abc5c1dd90870762d Juel became a registered member http://www.nationalboardinstitute.com/activity/p/27938/ Tue, 28 Jan 2025 10:21:33 -0800 0